While some previous studies in cognitively healthy older adults have reported higher plasma p-tau181 in APOE ε4 carriers compared to non-APOE ε4 carriers [33], no such difference was observed between APOE ε4 carriers and non-carriers among patients on the AD continuum [34,35]. The gene discussed is APOE; the disease is Alzheimer disease.